Browsing: Alzheimer’s

The FDA launched the Neuroscience Advancement and Innovation Nexus to accelerate medical product development for brain conditions, starting with Alzheimer’s prevention.

A new UK clinical trial is testing repurposed diabetes and ADHD medicines to treat Alzheimer’s disease, aiming to speed up the discovery of effective treatments.

Researchers at the University of Bonn have reversed more than 60 years of aging in human cells by transforming old blood cells into young neural stem cells.

New research shows 3,000 steps daily reduces tau protein buildup, slowing Alzheimer’s progression. Experts say modest activity targets are realistic for older adults.

A rare examination of an Alzheimer’s patient’s brain reveals that regions where amyloid plaques were cleared showed significantly less tau damage than areas where plaques remained.

Scientists have identified the P2X7 receptor as a key driver of brain inflammation. Blocking this target significantly reduced inflammatory responses in human tissue samples.